Prominent IP Updates on Apr 23, 2015

Quaker files patent on expandable package for heated food

A patent from the Quaker Oats Co. relates to reducing the headspace between the food inside a package to be heated, such as in a microwave, and the package’s lid. The reduced headspace should save on shipping costs.

Read More

Google Glass patent shows split hardware, ‘normal’ form-factor

A new patent has surfaced which might show the direction Google is headed with Glass. Though it hasn’t changed much, the core hardware is being split up; likely a response to those who weren’t comfortable with a head-mounted camera ready to shoot.

Read More

Patent Issued for System and Method for Interactive Voice Response Unit Table-Based Programming

Hartford Fire Insurance Company has been issued US patent number 9008285 that describes Interactive voice response (IVR) systems involve a technology that permits a programmed machine (e.g., computer system) to provide interactive voice responses to callers.

Read More

US Patent Granted for Batu Biologics Cancer Immunotherapeutic Product ImmXcyteTM

Batu Biologics announced the issuance of United States patent 8999349 covering composition of matter claims for its ImmXcyteTM immune-oncology peptide technology. ImmXcyteTM is a potent stimulator of immune responses developed by University of California San Diego (UCSD) and exclusively licensed to Batu Biologics.

Read More

BDT patents new Tornado application

BDT has patented a new application for its Tornado paper transport technology, to create shingled streams of media.

Read More

Serodus Files Patent Application in UK To Begin Pulmonary Hypertension Therapy Development

Serodus ASA recently announced that the company has filed a provisional patent application with the United Kingdom patent office for its experimental SER100 therapy, which will begin development for treatment of Pulmonary Hypertension.

Read More

Hedge fund manager targets patent for Biogen’s blockbuster MS drug, Tecfidera

A group founded earlier this year by hedge fund manager Kyle Bass aimed at filing patent challenges against drug companies and profiting off the resulting stock drop has targeted Biogen’s patent No. 8759393 for blockbuster multiple sclerosis drug, Tecfidera. Biogen’s Tecfidera was the biggest locally-developed drug to be approved in the U.S. in 2013. It’s expected to make more than $4 billion in revenue, which is currently Biogen’s top seller.

Read More

Patent Issued for Zero-Pressure Balloon Catheter and Method for Using the Catheter

Mayser, LLC has been awarded US patent 9005165 for an invention that relates to a catheter, especially a flexible pressure-limiting or zero-pressure balloon catheter and a method for using the catheter.

Read More

Apple patents a touchscreen that emulates different materials thanks to vibrations, temperature

The latest addition to Apple’s invention portfolio is a touch screen display that can simulate the feel of various materials. The patent has been granted by the USPTO on April 23, and explains that the display makes use of an actuator to vibrate the surface of the screen and change its temperature in order to fool users that they are not touching a plastic display, but a material of other origin.

Read More

Marina Biotech Expands Global Patent Protection of Clinical Stage Nucleic Acid Delivery …

Marina Biotech has been Granted EP Process Patent and Four National Patents Covering Its tkRNAi, SMARTICLES and DILA2 Delivery Technologies. The company has earlier received an EP process patent for liposome synthesis and continues to rapidly expand its global patent portfolio.

Read More

Apple’s “Live Listen” is now a Registered Trademark

On April 22, 2015, the U.S. Patent & Trademark Office published Apple’s latest registered trademark for “Live Listen” which was issued to Apple officially yesterday.

Read More

Leave a Reply